Your new experience awaits. Try the new design now and help us make it even better

CONCEPTUAL ANALYSIS article

Front. Vet. Sci.

Sec. Anesthesiology and Animal Pain Management

Timing-Controlled Concept for Extubation in Brachycephalic Dogs: α2–Bridged On-Demand Extubation

Provisionally accepted
  • 1JAVA Incorporated Association, Tokyo, Japan
  • 2Gifu Daigaku, Gifu, Japan

The final, formatted version of the article will be published soon.

Brachycephalic dogs are overrepresented among peri-and post-anesthetic respiratory complications, and many serious adverse events in small animals cluster around extubation and early recovery. A recurring clinical problem is a mismatch between apparent behavioral emergence and incomplete recovery of upper-airway stability, such that extubation may occur while residual anesthetic effect still depresses pharyngeal dilator activity and protective reflexes. Brachycephalic dogs have anatomically constrained, load-sensitive upper airways, making emergence a phase in which behavioral arousal may precede full recovery of airway stability. We propose a timing-controlled concept for extubation in brachycephalic dogs—α2–Bridged On-Demand Extubation (A2-ODE)— that decouples volatile washout from the timing of awakening and extubation. In A2-ODE, the vaporizer is turned off and washout is completed, as far as practicable, while the airway remains secured under a low-to moderate-dose α2-agonist sedative bridge; awakening is then intentionally triggered by atipamezole immediately before planned extubation. The sequence is designed to avoid extubation within a volatile-associated vulnerable emergence range, stabilize the emergence phenotype, and provide clinician-controlled timing of wakefulness and extubation. We outline a stepwise protocol, discuss key prerequisites, limitations and hemodynamic considerations, and propose testable predictions for prospective clinical and physiologic studies in brachycephalic patients. This is a conceptual, hypothesis-generating article; A2-ODE is intended as a framework for future clinical studies rather than a validated protocol for routine use.

Keywords: Atipamezole, Brachycephalic dogs, Brachycephalicobstructive airway syndrome, Extubation, Recovery, Upper-airway obstruction, Volatileanesthetics, α2 adrenergic agonists

Received: 07 Dec 2025; Accepted: 11 Feb 2026.

Copyright: © 2026 Nagahama. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Shotaro Nagahama

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.